这种rv2820c K114N突变与capreomycin耐受性有关
Jin-Tian Xu1, Yi Lin1, Tao Cheng1
1Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
Tuberculosis (Edinburgh, Scotland)
|July 31, 2024
概括
在rv2820c基因 (K114N) 中的一种突变与Mycobacterium tuberculosis的菌素耐受性有关. 这一发现表明了影响这种严重感染治疗结果的新因素.
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 药物耐药性 药物耐药性 药物耐药性
背景情况:
- 菌根性细菌病的药物耐受性是影响治疗结果的尚未研究的因素.
- 全基因组关联研究 (GWAS) 对于确定药物耐药性的遗传决定因素至关重要.
- 卡普雷奥米辛是一种重要的二线抗生素,用于治疗多药耐药结核病.
研究的目的:
- 调查rv2820c基因突变 (K114N) 在Mycobacterium结核病中卡普雷米辛耐药性和耐受性的作用.
- 确定rv2820c K114N突变对capreomycin体外活性的影响.
- 探索潜在的新机制的药物耐受性在真菌细菌感染.
主要方法:
- 在607个Mycobacterium结核病临床分离物上进行全基因组关联研究 (GWAS),并进行表型药物敏感性测试.
- 在Mycobacterium smegmatis (Ms) 中,完整的rv2820c基因和rv2820c K114N突变的过度表达.
- 最低抑制度 (MIC) 确定和时间杀死试验,以评估capreomycin活性.
主要成果:
- rv2820c K114N突变在耐卡普雷奥米辛的分离物中显著丰富,但也存在于敏感的分离物中.
- 这种K114N突变并没有改变对Mycobacterium smegmatis的卡普雷奥米辛的MIC.
- 时间杀死试验表明,在雷米辛压力下K114N突变的细菌存活率增加,表明耐受性.
结论:
- 这种rv2820c K114N突变与Mycobacterium tuberculosis的菌耐受性有关,而不是耐药性.
- 这种突变可能代表了一种新的机制,有助于解决菌根性细菌病的治疗挑战.
- 需要进一步的研究来阐明rv2820c K114N在真菌细菌药物耐受性中的确切作用.
关键词:
卡普雷奥美辛是一种在GWAS中,GWAS就是GWAS.宽容是一种宽容.rv2820c K114NN K114NN rv2820c K114NN K114NN rv2820c K114NN K114更多相关视频
09:04Studying Ribonucleotide Incorporation: Strand-specific Detection of Ribonucleotides in the Yeast Genome and Measuring Ribonucleotide-induced Mutagenesis
Published on: July 26, 2018
7.7K
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Translation
14.7K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.7K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
